What Researchers Did
Researchers examined the types and amounts of bacteria in the throats of patients who received hyperbaric oxygen therapy (HBOT) at 2.2 ATA or 2.5 ATA, comparing them to a group who did not receive HBOT.
What They Found
The study isolated hundreds of bacterial strains, including Streptococcus, Staphylococcus, Klebsiella, and Nocardia, from patients' throats. They observed a reduction in the number of these bacterial strains after HBOT. The authors believe these changes are due to HBOT's effect on both the bacteria and the patient's immune response.
Canadian Relevance
No direct Canadian connection identified. This study was not conducted by Canadian authors or in Canada. It does not specifically cover a Health Canada-recognized indication for HBOT, but rather general bacterial flora changes.
Study Limitations
The abstract provides limited specific data on the extent of bacterial changes and does not discuss the clinical implications or long-term effects of these observations.